Comparison between ABH Healthcare IPO and FCML Distributors IPO.
ABH Healthcare IPO is a SME Bookbuilding IPO proposed to list at NSE SME while FCML Distributors IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of ABH Healthcare IPO is up to ₹0.00 Cr whereas the issue size of the FCML Distributors IPO is up to ₹0.00 Cr. The final issue price of ABH Healthcare IPO is and of FCML Distributors IPO is .
| ABH Healthcare IPO | FCML Distributors IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 34,29,000 shares | 45,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 11,46,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,29,000 shares | 57,42,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
ABH Healthcare IPO opens on , while FCML Distributors IPO opens on . The closing date of ABH Healthcare IPO and FCML Distributors IPO is , and , respectively.
ABH Healthcare IPO P/E ratio is , as compared to FCML Distributors IPO P/E ratio of .
| ABH Healthcare IPO | FCML Distributors IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)FCML Distributors Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 17% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 30.33% | 34.29% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.96% | 37.93% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.69 | 0.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.33% | 29.27% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the ABH Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in FCML Distributors IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in ABH Healthcare IPO and 0 shares in FCML Distributors IPO.
| ABH Healthcare IPO | FCML Distributors IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
ABH Healthcare IPO subscribed in total, whereas FCML Distributors IPO subscribed .
